Modifying perioperative blood loss.

Abstract:

:Fears about the risks of disease transmission through the transfusion of homologous blood, as well as problems with blood supply and cost have increased the interest in reducing perioperative bleeding. This article discusses the causes of non-surgical perioperative bleeding and attempts to reduce perioperative bleeding with pharmacological agents. There is particular emphasis on the effects of cardiopulmonary bypass on haemostasis as the majority of studies have been conducted in this area. The agents discussed include the use of fibrin sealants, antiplatelet agents such as dipyridamole and prostacyclin analogues, antifibrinolytics and the effects of desmopressin and aprotinin. Currently high dose aprotinin would appear to be the most efficacious method of reducing perioperative bleeding in cardiac surgery, although a full risk benefit analysis is not yet possible. The effectiveness of aprotinin and tranexamic acid in reducing the 'oozing' seen in any surgical patient suggests the contribution of fibrinolysis in causing perioperative bleeding has not been fully evaluated. More research is required in this actively growing area.

journal_name

Blood Rev

journal_title

Blood reviews

authors

Hunt BJ

doi

10.1016/0268-960x(91)90034-a

subject

Has Abstract

pub_date

1991-09-01 00:00:00

pages

168-76

issue

3

eissn

0268-960X

issn

1532-1681

pii

0268-960X(91)90034-A

journal_volume

5

pub_type

杂志文章,评审
  • Results of programmes for antenatal detection of thalassemia in reducing the incidence of the disorder.

    abstract::The characteristics and the effectiveness of programmes designed to prevent beta-thalassemia major present in high frequency in several areas of the world such as Cyprus, Greece and Sardinia are reviewed. All these programmes are based on heterozygote detection, counselling and foetal diagnosis. The target population ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(87)90032-4

    authors: Cao A

    更新日期:1987-09-01 00:00:00

  • Platelet-neutrophil interactions: their significance.

    abstract::In the vicinity of an acute inflammatory response both cellular and non-cellular elements may interact to modify the overall response. Evidence suggests that leukocytes may play an active role in the modulation of platelet function and vice-versa. This interaction may be abnormal in certain pathological states. Neutro...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(92)90010-n

    authors: Faint RW

    更新日期:1992-06-01 00:00:00

  • Controversies surrounding iron chelation therapy for MDS.

    abstract::The myelodysplastic syndromes (MDS) are characterized by cytopenias and acute myeloid leukemia risk. Most MDS patients eventually require transfusion of red blood cells for anemia, placing them at risk of iron overload (IOL). In beta-thalassemia major, transfusional IOL leads to organ dysfunction and death, however, w...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2010.09.003

    authors: Leitch HA

    更新日期:2011-01-01 00:00:00

  • Transfusion-associated graft-versus-host disease and its prevention.

    abstract::Transfusion-associated graft-versus-host disease is a rare but usually fatal complication of transfusion of cellular blood components, caused by multiorgan engraftment and proliferation of donor T lymphocytes. The classical features of skin rash, diarrhoea and hepatitis, along with striking bone-marrow failure, are se...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(95)90016-0

    authors: Williamson LM,Warwick RM

    更新日期:1995-12-01 00:00:00

  • Intensive chemotherapy in myelodysplastic syndromes.

    abstract::Patients with myelodysplastic syndrome (MDS) who have more than 10% blasts in their bone marrow have a very short survival. Treatment has not improved for these patients for the past 10 years and supportive care alone is still the gold standard. Intensive chemotherapy for poor prognosis MDS has been little tried, but ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(92)90017-k

    authors: Hamblin TJ

    更新日期:1992-12-01 00:00:00

  • Management of refractory idiopathic thrombocytopenia.

    abstract::In refractory thrombocytopenia one should first evaluate whether the therapeutic approach has more risks to the patient than no treatment at all. The patient may remain relatively asymptomatic and the only incommoding circumstances be cosmetic. Coincidental medical problems such as hypertension and peptic ulceration a...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(88)90020-3

    authors: Firkin BG,Hunt HA,Jane SM

    更新日期:1988-09-01 00:00:00

  • Childhood immune thrombocytopenic purpura.

    abstract::Childhood immune thrombocytopenic purpura (ITP) is acute and generally seasonal in nature, suggesting that infectious or environmental agents may trigger the immune response to produce platelet-reactive autoantibodies 4 to 8 weeks following an infection. In general, the patient is well apart from the diffuse bruising ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1054/blre.2001.0177

    authors: Nugent DJ

    更新日期:2002-03-01 00:00:00

  • Targeting platelet receptor function in thrombus formation: the risk of bleeding.

    abstract::In this review, we presume that the process of thrombus formation, as assessed in whole blood flow studies and in experimental (murine) thrombosis studies, reflects the platelet responses in human haemostasis and thrombosis. Following this concept, we give an up-to-date overview of the main platelet receptors and sign...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2013.12.001

    authors: Swieringa F,Kuijpers MJ,Heemskerk JW,van der Meijden PE

    更新日期:2014-01-01 00:00:00

  • Optimizing platelet transfusion therapy.

    abstract::Platelet transfusions are widely used. Prophylactic transfusions are employed in severely thrombocytopenic patients without evidence of bleeding, but no randomized trial data prove the safety or efficacy of this approach. Randomized trials have demonstrated the equivalence of transfusion triggers of 10,000 and 20,000/...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/S0268-960X(03)00057-2

    authors: Heal JM,Blumberg N

    更新日期:2004-09-01 00:00:00

  • Management of challenging myelofibrosis after JAK inhibitor failure and/or progression.

    abstract::The myeloproliferative neoplasms (MPNs) encompass a heterogenous set of diseases that have variable survival, but in the setting of treatment refractory and progressive disease, prognosis has been characteristically poor. JAK inhibition with ruxolitinib or fedratinib therapy has become the first line treatment for sym...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2020.100716

    authors: Scherber RM,Mesa RA

    更新日期:2020-07-01 00:00:00

  • MicroRNAs in hematological malignancies.

    abstract::MicroRNAs (miRNAs) have become one of the hottest topics in biology over recent years, but remarkably have only been formally recognized for just over 10 years. These endogenously produced short (19-24 nt) non-coding RNAs have introduced an entirely new paradigm in our understanding of gene control and it is now evide...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2013.04.002

    authors: Lawrie CH

    更新日期:2013-05-01 00:00:00

  • Myelodysplasic syndromes: a comprehensive review.

    abstract::Myelodysplastic syndromes (MDS) are a set of oligoclonal disorders of hematopoietic stem cells characterized by ineffective hematopoiesis that manifest clinically as anemia, neutropenia, and/or thrombocytopenia of variable severity. The result often is transfusion-dependent anemia, an increased risk of infection or he...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2005.01.004

    authors: Catenacci DV,Schiller GJ

    更新日期:2005-11-01 00:00:00

  • Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia.

    abstract::Parenteral arsenic trioxide (ATO) has been firmly established as a standard therapy for acute promyelocytic leukemia (APL). Despite widespread use of oral arsenicals in medicine historically, they had disappeared from modern pharmacopeia until oral ATO was redeveloped in Hong Kong in 2000. Since then, over 200 patient...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2015.11.004

    authors: Torka P,Al Ustwani O,Wetzler M,Wang ES,Griffiths EA

    更新日期:2016-05-01 00:00:00

  • A logical approach to the investigation of red cell enzymopathies.

    abstract::This relatively rare group of disorders may cause quite marked morbidity and occasionally be life-threatening. As their inheritance is largely known accurate information in one family member has obvious benefits to other family members as well as the patient. The identification of the defect is dependent on an accurat...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(90)90042-q

    authors: Lestas AN,Bellingham AJ

    更新日期:1990-09-01 00:00:00

  • Therapeutic strategies in low and high-risk MDS: What does the future have to offer?

    abstract::Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid disorders characterized by cytopenias and increased risk of acute leukemia transformation. Prognosis of MDS patients can be assessed by various scoring systems, the most common being the International Prognostic Scoring System (IPSS) now refined by t...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2020.100689

    authors: Scalzulli E,Pepe S,Colafigli G,Breccia M

    更新日期:2020-03-31 00:00:00

  • Enzyme therapy for Gaucher disease: the first 5 years.

    abstract::Gaucher disease was first described by Philippe Gaucher in his 1882 medical thesis. Gaucher's original concept was of an unusual epithelioma of the spleen. By the early 1900s, Mandelbaum recognized the systemic nature of the disease. Several children with Gaucher disease were described at the turn of the century, but ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(98)90023-6

    authors: Grabowski GA,Leslie N,Wenstrup R

    更新日期:1998-06-01 00:00:00

  • Biochemistry of factor X.

    abstract::Factor X circulates as a serine protease which is converted to the active form at the point of convergence of the intrinsic and extrinsic coagulation pathways. Subsequently, the enzymatic species, factor Xa, is involved in macromolecular complex formation with its cofactor factor Va, a phospholipid surface and calcium...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(94)90007-8

    authors: Hertzberg M

    更新日期:1994-03-01 00:00:00

  • Using prognostic models in CLL to personalize approach to clinical care: Are we there yet?

    abstract::Four decades ago, two staging systems were developed to help stratify CLL into different prognostic categories. These systems, the Rai and the Binet staging, depended entirely on abnormal exam findings and evidence of anemia and thrombocytopenia. Better understanding of biologic, genetic, and molecular characteristics...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2017.10.003

    authors: Mina A,Sandoval Sus J,Sleiman E,Pinilla-Ibarz J,Awan FT,Kharfan-Dabaja MA

    更新日期:2018-03-01 00:00:00

  • Iron toxicity - Its effect on the bone marrow.

    abstract::Excess iron can be extremely toxic for the body and may cause organ damage in the absence of iron chelation therapy. Preclinical studies on the role of free iron on bone marrow function have shown that iron toxicity leads to the accumulation of reactive oxygen species, affects the expression of genes coding for protei...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2018.04.004

    authors: Isidori A,Borin L,Elli E,Latagliata R,Martino B,Palumbo G,Pilo F,Loscocco F,Visani G,Cianciulli P

    更新日期:2018-11-01 00:00:00

  • Systematic review of staging bone marrow involvement in B cell lymphoma by flow cytometry.

    abstract::The clinical relevance of flow cytometry (FC)-based bone marrow involvement (BMI) in B cell non-Hodgkin lymphoma (B-NHL) is not well established. We conducted a systematic review of MEDLINE regarding the use of FC to establish BMI in B-NHL to determine the prevalence of BMI by FC, to understand the interrelation betwe...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2020.100778

    authors: Sorigue M,Cañamero E,Miljkovic MD

    更新日期:2020-11-08 00:00:00

  • Hemophilia A in the third millennium.

    abstract::Hemophilia A is an X-linked hereditary bleeding disorder due to the deficiency of coagulation factor VIII (FVIII). According to the degree of FVIII deficiency, mild, moderate or severe forms are recognized. Although patients with mild hemophilia A usually bleed excessively only after trauma or surgery, those with seve...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2013.06.002

    authors: Franchini M,Mannucci PM

    更新日期:2013-07-01 00:00:00

  • Cerebral venous thrombosis-a primer for the haematologist.

    abstract::Cerebral venous thrombosis (CVT) is a condition that can affect all age groups and can often be difficult to diagnose and treat. The difficulties in diagnosis are mainly due to the non-specific presenting features of CVT, which can range from isolated headache and visual or auditory problems, to serious symptoms such ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2014.09.006

    authors: Thorell SE,Parry-Jones AR,Punter M,Hurford R,Thachil J

    更新日期:2015-01-01 00:00:00

  • Hemophagocytic syndromes.

    abstract::Hemophagocytic syndromes (hemophagocytic lymphohistiocytosis, HLH) represent a severe hyperinflammatory condition with the cardinal symptoms prolonged fever, cytopenias, hepatosplenomegaly, and hemophagocytosis by activated, morphologically benign macrophages. Biochemical markers include elevated ferritin and triglyce...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2007.05.001

    authors: Janka GE

    更新日期:2007-09-01 00:00:00

  • MDS: Refining existing therapy through improved biologic insights.

    abstract::Advances in therapy can essentially be measured using two parameters; introduction of a new agent which benefits an increased number of patients over prevailing treatments or more selective use of an existing drug by matching it to the biologic characteristics associated with response. In reviewing the therapeutic lan...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2011.11.001

    authors: Schecter J,Galili N,Raza A

    更新日期:2012-03-01 00:00:00

  • Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding.

    abstract::Stimulation with the vasopressin analogue desmopressin (DDAVP) of extrarenal arginine vasopressin (AVP) V2-receptors in endothelial cells and possible in platelets increases the circulating levels of coagulation factor VIII (FVIII), von Willebrand factor (VWF) and tissue plasminogen activator (t-PA). The purpose of th...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2014.03.001

    authors: Svensson PJ,Bergqvist PB,Juul KV,Berntorp E

    更新日期:2014-05-01 00:00:00

  • Amyloidosis.

    abstract::Amyloidosis is the generic term for a heterogeneous group of disorders characterised by the common finding of amyloid deposition. The various acquired and hereditary syndromes are classified according to the identity of the respective amyloid fibril sub-unit protein. Systemic amyloidosis and some local forms are progr...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(95)90032-2

    authors: Hawkins PN

    更新日期:1995-06-01 00:00:00

  • The emerging role of red blood cells in cytokine signalling and modulating immune cells.

    abstract::For many years red blood cells have been described as inert bystanders rather than participants in intercellular signalling, immune function, and inflammatory processes. However, studies are now reporting that red blood cells from healthy individuals regulate immune cell activity and maturation, and red blood cells fr...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2019.100644

    authors: Karsten E,Herbert BR

    更新日期:2020-05-01 00:00:00

  • Treatment of hematological malignancies relapsing after allogeneic bone marrow transplantation.

    abstract::The rate of relapse after allogeneic bone marrow transplantation (BMT) varies between 15 and 60%. New therapeutic strategies are required urgently as no significant results have been obtained with standard chemotherapy. The best results of second allogeneic BMT have been obtained when the interval between the first an...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(94)90111-2

    authors: Boiron JM,Cony-Makhoul P,Mahon FX,Pigneux A,Puntous M,Reiffers J

    更新日期:1994-12-01 00:00:00

  • Neutrophil extracellular traps (NETs) and infection-related vascular dysfunction.

    abstract::The innate immune system orchestrated by leukocytes primarily neutrophils, serves to remove dead and dying host cells and to provide protection against invasion by pathogens. Failure of this system results in the onset of sepsis leading to grave consequences for the host. Together with mechanical methods to physically...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2012.09.001

    authors: Gardiner EE,Andrews RK

    更新日期:2012-11-01 00:00:00

  • Challenging the concept of de novo acute myeloid leukemia: Environmental and occupational leukemogens hiding in our midst.

    abstract::Myeloid neoplasms like acute myeloid leukemia (AML) originate from genomic disruption, usually in a multi-step fashion. Hematopoietic stem/progenitor cell acquisition of abnormalities in vital cellular processes, when coupled with intrinsic factors such as germline predisposition or extrinsic factors such as the marro...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2020.100760

    authors: Shallis RM,Weiss JJ,Deziel NC,Gore SD

    更新日期:2020-09-22 00:00:00